R. Rox Anderson
|Richard Rox Anderson|
|Born||30 October 1950|
|Residence||Boston, Massachusetts, U.S.|
Massachusetts Institute of Technology|
Harvard Medical School
Richard Rox Anderson, FAAD, is a Boston-based dermatologist and entrepreneur.
Education and Career
Anderson acquired his BS degree from MIT, and then pursued his MD degree graduating magna cum laude from the joint MIT-Harvard medical program, Health Sciences and Technology. Dr. Anderson completed his residency in dermatology and research fellowship at Harvard.
Upon completing his dermatology residency and research fellowship he became a part of the Harvard staff where he eventually became a professor in dermatology and the Director of the Wellman Center for Photomedicine at Massachusetts General Hospital. He also serves as an adjunct Professor of Health Sciences and Technology at MIT.
Anderson's contributions include laser hair removal, photodynamic therapy (use of light-activated localized drugs for cancer and macular degeneration), and basic research into the free electron laser for the selective destruction of lipids (i.e., fats) for possible treatment of acne, cellulite, and atherosclerosis, as well as various uses of photothermolysis using pulsed dye lasers.
Anderson and colleagues invented a crude device to noninvasively remove fat by freezing it, in a process called cryolipolysis; and a startup company called Juniper Medical exclusively licensed patent filings on the invention from Massachusetts General Hospital when Juniper was founded; Juniper became Zeltiq Aesthetics.
In the mid 2000s Anderson invented a tattoo ink designed to simplify tattoo removal called "InfinitInk". The ink is encapsulated in tiny plastic beads; the encapsulated ink is stable in normal light, but under the same kind of laser light used in laser tattoo removal, the ink is released from the beads and is absorbed. Anderson co-founded a company called Freedom-2 to bring the ink to market. with assistance from Edith Mathiowitz, Joshua Reineke and A. Peter Morello of Brown University.
- "Meet one of the most important medical entrepreneurs you've never heard of - The Boston Globe". BostonGlobe.com. Retrieved 2017-11-01.
- "2008 Visiting Professor - R. Rox Anderson, M.D." Oregon Health & Science University. Retrieved 2017-11-01.
- "The Wellman Center for Photomedicine: Faculty: Rox Anderson, MD". wellman.massgeneral.org. Retrieved 2017-11-01.
- "Richard Rox Anderson, MD - Department of Dermatology - Massachusetts General Hospital, Boston, MA". www.massgeneral.org. Retrieved 2017-11-01.
- Anderson, Rox (2000). Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems X (Proceedings of Spie). Spie. ISBN 978-0-8194-3523-1.
- Jancin, Bruce (April 2009). "Cryolipolysis on Track to Become First Cool Way to Remove Cellulite". Skin & Allergy News. 40. p. 11.
- "Zeltiq Amendment No. 8 to Form S-1". Zeltiq via SEC Edgar. 18 October 2011.
- Jaffe, Eric (January 1, 2007). "The Tattoo Eraser: A new type of body art ink promises freedom from forever". Smithsonian Magazine.
- Frederick, Robert (2006-09-25). "Harvard Tattoo Process May Ease a Change of Heart". National Public Radio (NPR).
- Cromie, William J. (2006-10-19). "Body art for the faint of heart: Erasable tattoos are making a mark". Harvard Gazette. Archived from the original on November 4, 2006.
- Halford, Bethany (October 31, 2016). "Olivo Laboratories". Chemical & Engineering News.